Aethlon Medical (AEMD, Financial) experienced a significant drop in its stock value, falling by 24% after the company reported earnings that failed to meet market expectations. This decline in AEMD's stock price highlights investor disappointment with the financial results, which did not align with anticipated performance metrics. The sharp downturn reflects the broader uncertainty investors feel about the company's future prospects following this earnings report.
Wall Street Analysts Forecast
Based on the one-year price targets offered by 1 analysts, the average target price for Aethlon Medical Inc (AEMD, Financial) is $4.50 with a high estimate of $4.50 and a low estimate of $4.50. The average target implies an upside of 131.96% from the current price of $1.94. More detailed estimate data can be found on the Aethlon Medical Inc (AEMD) Forecast page.
Based on the consensus recommendation from 2 brokerage firms, Aethlon Medical Inc's (AEMD, Financial) average brokerage recommendation is currently 2.5, indicating "Outperform" status. The rating scale ranges from 1 to 5, where 1 signifies Strong Buy, and 5 denotes Sell.
Based on GuruFocus estimates, the estimated GF Value for Aethlon Medical Inc (AEMD, Financial) in one year is $99.64, suggesting a upside of 5036.08% from the current price of $1.94. GF Value is GuruFocus' estimate of the fair value that the stock should be traded at. It is calculated based on the historical multiples the stock has traded at previously, as well as past business growth and the future estimates of the business' performance. More detailed data can be found on the Aethlon Medical Inc (AEMD) Summary page.
